[
    [
        {
            "time": "",
            "original_text": "健帆生物：单一产品贡献9成收入和毛利，集采危机两个万股价下跌超40% 经营问题",
            "features": {
                "keywords": [
                    "健帆生物",
                    "单一产品",
                    "收入",
                    "毛利",
                    "集采",
                    "股价下跌",
                    "经营问题"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "健帆生物：单一产品贡献9成收入和毛利，集采危机两个万股价下跌超40% 经营问题",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "新冠检测板块大涨，疫情仍在路上投资价值凸显",
            "features": {
                "keywords": [
                    "新冠检测",
                    "板块大涨",
                    "疫情",
                    "投资价值"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "新冠检测板块大涨，疫情仍在路上投资价值凸显",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "新冠检测板块午后持续拉升，医疗器械ETF（159883）涨幅扩大至4.46％！",
            "features": {
                "keywords": [
                    "新冠检测",
                    "板块拉升",
                    "医疗器械ETF",
                    "涨幅"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "新冠检测板块午后持续拉升，医疗器械ETF（159883）涨幅扩大至4.46％！",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 10,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]